Determination and pharmacokinetic profile of pyrazinamide in rat blood, brain and bile using microdialysis coupled with high-performance liquid chromatography and verified by tandem mass spectrometry
Authors:
- 1 September 2004
- journal article
- Published by Elsevier in Analytica Chimica Acta
- Vol. 522 (2) , 231-239
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The effects of the cyclosporin A, a P‐glycoprotein inhibitor, on the pharmacokinetics of baicalein in the rat: a microdialysis studyBritish Journal of Pharmacology, 2002
- Effect of P‐glycoprotein modulators on the pharmacokinetics of camptothecin using microdialysisBritish Journal of Pharmacology, 2001
- Pharmacokinetics of pefloxacin and its interaction with cyclosporin A, a P‐glycoprotein modulator, in rat blood, brain and bile, using simultaneous microdialysisBritish Journal of Pharmacology, 2001
- Methodological considerations of intracerebral microdialysis in pharmacokinetic studies on drug transport across the blood–brain barrierBrain Research Reviews, 1997
- In vitro protein binding characteristics of isoniazid, rifampicin, and pyrazinamide to whole plasma, albumin, and α-1-acid glycoproteinClinical Biochemistry, 1996
- The blood/cerebrospinal fluid partitioning of pyrazinamide: a study during the course of treatment of tuberculous meningitis.Journal of Neurology, Neurosurgery & Psychiatry, 1990
- Penetration of pyrazinamide into the cerebrospinal fluid in tuberculous meningitis.BMJ, 1987
- Pyrazinamide in Treatment of Tuberculous MeningitisArchives of Neurology, 1986
- In vitro andin vivo evaluation of the tissue-to-blood partition coefficient for physiological pharmacokinetic modelsJournal of Pharmacokinetics and Biopharmaceutics, 1982
- Syntheses in the Pyrazine Series. II. Preparation and Properties of AminopyrazineJournal of the American Chemical Society, 1940